| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.54 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |